Novo Nordisk | driving change to defeat serious chronic diseases
WEBNovo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk Patient Assistance Program (PAP) | NovoCare®
WEBFind inspiration and motivation for staying active, eating healthy, and building up your knowledge with resources and education from NovoCare. Apply for the Novo Nordisk Patient Assistance Program (PAP) to see if you qualify to receive your Novo Nordisk diabetes medicine at no cost.
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
WEBLearn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Novo Nordisk - Wikipedia
WEBNovo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. [5] Its main product is the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. [6]
Novo Nordisk A/S (NVO) Stock Price, News, Quote & History ...
WEBFind the latest Novo Nordisk A/S (NVO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Patient Assistance Program for People with Diabetes - NovoCare
WEBLearn about the Novo Nordisk Patient Assistance Program (PAP) for people with diabetes and find out if your patients qualify to receive medication at no cost.
Who we are - Novo Nordisk
WEBNovo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
Skip to content